JP2015501791A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501791A5
JP2015501791A5 JP2014540950A JP2014540950A JP2015501791A5 JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5 JP 2014540950 A JP2014540950 A JP 2014540950A JP 2014540950 A JP2014540950 A JP 2014540950A JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5
Authority
JP
Japan
Prior art keywords
methoxyethyl
gataparsen
m5ru
manufactured
thoxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540950A
Other languages
English (en)
Japanese (ja)
Other versions
JP5923177B2 (ja
JP2015501791A (ja
Filing date
Publication date
Priority claimed from KR1020110117082A external-priority patent/KR101383324B1/ko
Application filed filed Critical
Publication of JP2015501791A publication Critical patent/JP2015501791A/ja
Publication of JP2015501791A5 publication Critical patent/JP2015501791A5/ja
Application granted granted Critical
Publication of JP5923177B2 publication Critical patent/JP5923177B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540950A 2011-11-10 2012-11-09 新規な遺伝子伝達用組成物 Active JP5923177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2011-0117082 2011-11-10
KR1020110117082A KR101383324B1 (ko) 2011-11-10 2011-11-10 신규한 유전자 전달용 조성물
PCT/KR2012/009443 WO2013070010A1 (en) 2011-11-10 2012-11-09 Novel composition for gene delivery

Publications (3)

Publication Number Publication Date
JP2015501791A JP2015501791A (ja) 2015-01-19
JP2015501791A5 true JP2015501791A5 (enExample) 2015-05-21
JP5923177B2 JP5923177B2 (ja) 2016-05-24

Family

ID=48290305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540950A Active JP5923177B2 (ja) 2011-11-10 2012-11-09 新規な遺伝子伝達用組成物

Country Status (6)

Country Link
US (1) US9173853B2 (enExample)
EP (1) EP2776056B1 (enExample)
JP (1) JP5923177B2 (enExample)
KR (1) KR101383324B1 (enExample)
ES (1) ES2621403T3 (enExample)
WO (1) WO2013070010A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US9493430B2 (en) 2013-01-31 2016-11-15 Chong Kun Dang Pharmaceutical Corp. Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors
KR101601035B1 (ko) 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
CL2014003514A1 (es) * 2014-12-23 2015-05-08 Univ De Concepción Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.
KR101916193B1 (ko) 2016-08-25 2018-11-07 주식회사 파마리서치프로덕트 핵산 및 키토산을 포함하는 관절강 주사용 조성물
EP3612215B1 (en) 2017-04-20 2024-08-28 aTyr Pharma, Inc. Compositions for treating lung inflammation
PE20210685A1 (es) 2018-07-03 2021-04-08 Gilead Sciences Inc Anticuerpos que se dirigen al gp120 de vih y metodos de uso
PE20220231A1 (es) 2019-06-25 2022-02-07 Gilead Sciences Inc Proteinas de fusion flt3l-fc y metodos de uso
EP3999107A1 (en) 2019-07-16 2022-05-25 Gilead Sciences, Inc. Hiv vaccines and methods of making and using
EP4458975A3 (en) 2019-09-30 2025-02-12 Gilead Sciences, Inc. Hbv vaccines and methods treating hbv
CA3128035A1 (en) 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier
TWI815194B (zh) 2020-10-22 2023-09-11 美商基利科學股份有限公司 介白素2-Fc融合蛋白及使用方法
CN119677546A (zh) 2022-07-12 2025-03-21 吉利德科学公司 Hiv免疫原性多肽和疫苗及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008202A (en) 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
EP1045699A1 (en) * 1998-01-16 2000-10-25 The Johns Hopkins University Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
US20030134810A1 (en) * 2001-10-09 2003-07-17 Chris Springate Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
WO2004074314A2 (en) * 2003-02-14 2004-09-02 University Of South Florida Chistosan-microparticles for ifn gene delivery
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
KR100825519B1 (ko) 2007-01-05 2008-04-25 주식회사 바이오폴리메드 키토산 기재 고분자 접합체 및 그 제조방법
US20110038941A1 (en) 2007-12-27 2011-02-17 The Ohio State University Research Foundation Lipid Nanoparticle Compositions and Methods of Making and Using the Same
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물

Similar Documents

Publication Publication Date Title
JP2015501791A5 (enExample)
JP2013542247A5 (enExample)
EA201170039A1 (ru) Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения
JP2013507423A5 (enExample)
WO2014004436A3 (en) Crystalline anti-human il-23 antibodies
BR112014014599A8 (pt) polímeros de alfa-aminoamidina e uso dos mesmos
EA201890236A1 (ru) Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
JP2013032389A5 (enExample)
SG10201804024VA (en) Formulations of azaindole compounds
HK1214499A1 (zh) 穩定的低粘度抗體配製品
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
JP2015007131A5 (enExample)
MA35130B1 (fr) Composition comprenant de l'aflibercept, de l'acide folinique, du 5-fluoro-uracile (5-fu) et de l'irinocetan (folfiri)
MY178888A (en) Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same
JP2014097964A5 (enExample)
JP2017517533A5 (enExample)
CA2920410C (en) Thienopiperidine derivative and use thereof
JP2015509075A5 (enExample)
JP2013518036A5 (enExample)
JP2013535445A5 (enExample)
WO2014081968A8 (en) Compositions of low sodium salt and methods of making and using
JP2014500250A5 (enExample)
WO2010080754A3 (en) Nanoparticle pharmaceutical formulations
DOP2011000032A (es) Composicion farmaceutica solida
RU2015110285A (ru) Материалы носителя катализатора, катализаторы, способы их получения и применения